Kaleb Michaud, PhD
Professor, Division of Rheumatology
Director, Rheumatology Fellowship Research Program
Dr. Michaud spends much of his time leading and conducting research with patient registries. He serves as Director of the Forward Databank, the largest long-term open-cohort observational registry of its kind with more than 50,000 patients enrolled. Since 2007 he has been the principal investigator of the RAIN database, a rheumatology clinical registry composed of all five clinics within Nebraska Medicine. He is an active and long-term volunteer in the American College of Rheumatology and Association for Rheumatology Professionals, including eight years in developing the Rheumatology Informatics System for Effectiveness (RISE) national registry. He also works closely with Dr. Ted Mikuls on the Veteran Affairs Rheumatoid Arthritis (VARA) registry.
Dr. Michaud's research interests include pharmacoepidemiology, health outcomes, medical informatics, meta-analysis, quality of life, and cost-effectiveness in rheumatology. Some of his current projects include: DMARD adherence, mortality in rheumatic diseases, rheumatoid arthritis activity measures, and smartphone-detected health outcomes. Within the University of Nebraska Medical Center, he is the director of the rheumatology fellowship research program, chair of the Clinical Research Center pilot grant review committee, and leads the Great Plains IDEA-CTR Mentor Training Facilitator Team. He is dedicated to conducting research that improves care for those living with rheumatic diseases.
Information
- Patient Registries
- Outcomes research in RMDs with specialization in rheumatoid arthritis
- Pharmacovigilance
- Healthcare cost-effective analyses
- Undergraduate Education: BS, University of Rochester, 1997,
- Graduate Education: MS, Stanford University, 2001
- Graduate Education: PhD, Stanford University, 2006
Department of Internal Medicine
College of Medicine
University of Nebraska Medical Center
986270 Nebraska Medical Center
Omaha, NE 68198-6270
Dr. Kaleb Michaud, Ph.D., lead author, recently published a study about the experiences of patients who have rheumatic diseases early in the COVID-19 pandemic.